Avitinib (Synonyms: AC0010) |
رقم الكتالوجGC42884 |
Avitinib (AC0010) هو مثبط EGFR انتقائي لا رجعة فيه ، يمنع بشكل فعال طفرات مقاومة EGFR T790M في سرطان الرئة ذو الخلايا غير الصغيرة (NSCLC)Abivertinib هو أيضًا مثبط جديد لـ BTK
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1557267-42-1
Sample solution is provided at 25 µL, 10mM.
Avitinib is a pyrrolopyrimidine-based, irreversible inhibitor of the epidermal growth factor receptor (EGFR). It is selective for EGFR-active and T790M mutations, exhibiting a 298-fold increase in potency compared with wild-type EGFR. In a xenograft model, oral administration of 500 mg/kg avitinib was shown to result in complete remission of tumors with EGFR-active and T790M mutations.
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *